🇺🇸 FDA
Patent

US 9265818

Genetically modified Babesia parasites expressing protective tick antigens and uses thereof

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 9265818 (Genetically modified Babesia parasites expressing protective tick antigens and uses thereof) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K39/0003, A61K39/018